Challenge:
A South Korean consulting firm required support in exploratory partner outreach in the US and Europe. Alacrita was commissioned to use its expertise in pharma licensing and deal-making in these territories to gain an initial read on potential "partnerability" for two South Korean pharma companies.
Solution:
Alacrita’s experts reviewed data on each company and asset and created marketing materials, then using our industry expertise and existing network we shortlisted potential partners and arranged for meetings to be held at an upcoming partnering conference.
Alacrita led each partnering meeting, introducing contacts to each asset, gauging interest and collecting technical feedback on potential data gaps.
Once collated and relayed, the Korean consulting firm used this information to strengthen each company's pitch for investment and partnering in the US and Europe.
Pharma Out-Licensing, Partnering & Dealmaking Services
We provide a range of pharma licensing services, taking a flexible approach that can include dovetailing with your existing internal capabilities and activities, or taking on full-responsibility for your out-licensing efforts.
Back